Longteng Biotech

Jiangsu Longteng Biotechnology is a leading Chinese life sciences company specializing in the development and manufacture of high-end raw materials for molecular diagnostics and biopharmaceutical production. The company provides a comprehensive portfolio of high-performance enzymes, including Taq polymerase, reverse transcriptase, and T7 RNA polymerase, as well as high-purity dNTPs and diagnostic antibodies. These products are essential components for quantitative PCR (qPCR), next-generation sequencing (NGS), and mRNA vaccine manufacturing. Backed by prominent investors such as IDG Capital and Legend Capital, Longteng Biotech serves a global clientele of IVD manufacturers and research institutions, focusing on the upstream supply chain for infectious disease testing, oncology diagnostics, and genetic screening.